NYSE: BMY

Price$56.05 Change -0.22 %Change -0.4% Volume: 2,684,775 20 minute delay January 18, 2017

Stock Split History

Split Date Rate
February 20, 1945 2 for 1
July 9, 1959 3 for 1
October 7, 1963 2 for 1
October 10, 1966 2 for 1
April 28, 1977 2 for 1
April 28, 1983 2 for 1
June 9, 1987 (Issue Date)
May 12, 1987 (Record Date)
2 for 1
February 28, 1997 (Issue Date)
February 7, 1997 (Record Date)
2 for 1
February 26, 1999 (Issue Date)
February 5, 1999 (Record Date)
2 for 1

Bristol-Myers Squibb Company Corporate Actions

Record Date Description Rate
August 7, 2001 Zimmer Holdings, Inc. spin off from Bristol-Myers Squibb Company 10 BMY = 1 Zimmer

Squibb Corporation Corporate Actions

Record Date Description Rate
January 12, 1968 Squibb Beech-Nut Corp. spin off from
Olin Mathieson
1 Olin = 0.6695 Squibb Beech-Nut
May 20, 1974 Stock split 2 for 1
January 2, 1987 Westmark International spin off from Squibb Corp. 1 Westmark = 5 Squibb
June 1, 1987 Stock split 2 for 1
October 4, 1989 Squibb Corporation and Bristol-Myers Company merged to form Bristol-Myers Squibb Company 1 Squibb = 2.4 Bristol-Myers Squibb

This page is hosted by Q4 Web Systems. Bristol-Myers Squibb does not monitor, endorse or accept responsibility for the content posted on this page by Q4 Web Systems.

Materials on this website may contain information about the Company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents are available from the Securities and Exchange Commission, the Bristol-Myers Squibb website or from Bristol-Myers Squibb Investor Relations.

In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change, whether as a result of new information, future events or otherwise. Consequently, the company will not update the information contained on the website and investors should not rely upon the information as current or accurate after the presentation date. The website may also contain certain non-GAAP financial measures, adjusted to include certain costs, expenses, gains and losses and other specified items. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com.